{
  "trial_id": "NCT01961531",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, histological diagnosis, pathologic lymph node status, tumor size, estrogen receptor status, surgical margins, lymphovascular invasion status, ECOG performance status, life expectancy, breast separation with compression, presence of breast implants, presence of distant metastases, lumpectomy cavity visualization, psychiatric or addictive disorders, pregnancy status, BRCA 1/2 mutation status, presence of active lupus or scleroderma, neoadjuvant chemotherapy status, presence of suspicious remaining microcalcification, multicentric disease, Paget's disease of the nipple.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Sex: Female",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "histological diagnosis",
        "pathologic lymph node status",
        "tumor size",
        "estrogen receptor status",
        "surgical margins",
        "lymphovascular invasion status",
        "ECOG performance status",
        "life expectancy",
        "breast separation with compression",
        "presence of breast implants",
        "presence of distant metastases",
        "lumpectomy cavity visualization",
        "psychiatric or addictive disorders",
        "pregnancy status",
        "BRCA 1/2 mutation status",
        "presence of active lupus or scleroderma",
        "neoadjuvant chemotherapy status",
        "presence of suspicious remaining microcalcification",
        "multicentric disease",
        "Paget's disease of the nipple"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Race/Ethnicity, Customized, Region of Enrollment, Histological Diagnosis, Tumor Size, Estrogen Receptor Status, Surgical Margins, ECOG Performance Status,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Histological Diagnosis",
        "Tumor Size",
        "Estrogen Receptor Status",
        "Surgical Margins",
        "ECOG Performance Status"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Race/Ethnicity, Customized, Region of Enrollment, Menopausal Status, Tumor Size, Estrogen Receptor Status, Lymph Node Status, Surgical Margin Status, ECOG Performance Status,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Menopausal Status",
        "Tumor Size",
        "Estrogen Receptor Status",
        "Lymph Node Status",
        "Surgical Margin Status",
        "ECOG Performance Status"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, histological diagnosis (invasive breast carcinoma or DCIS), tumor size, estrogen receptor status, lymph node status, ECOG performance status, surgical margin status, presence of lymphovascular invasion, BRCA 1/2 mutation status, presence of active lupus or scleroderma, pregnancy status, psychiatric or addictive disorder status, neoadjuvant chemotherapy status, adjuvant chemotherapy status, presence of suspicious remaining microcalcification on post-surgery mammogram, multicentric disease status, Paget's disease of the nipple status, presence of breast implants, distant metastases status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "histological diagnosis (invasive breast carcinoma or DCIS)",
        "tumor size",
        "estrogen receptor status",
        "lymph node status",
        "ECOG performance status",
        "surgical margin status",
        "presence of lymphovascular invasion",
        "BRCA 1/2 mutation status",
        "presence of active lupus or scleroderma",
        "pregnancy status",
        "psychiatric or addictive disorder status",
        "neoadjuvant chemotherapy status",
        "adjuvant chemotherapy status",
        "presence of suspicious remaining microcalcification on post-surgery mammogram",
        "multicentric disease status",
        "Paget's disease of the nipple status",
        "presence of breast implants",
        "distant metastases status"
      ]
    }
  }
}